Partner David Rosen was quoted in an Inside Health Policy article on January 22, 2014 titled “Generic Drug Industry Prioritizes Challenge to New Labeling Rule in 2014.” The article discusses the top priority for the generic drug industry in 2014 which will be combating a new regulation aimed at requiring generic drugmakers to make labeling changes to reflect new safety information. Rosen was quoted saying, “I think it’s going to be a pretty big deal.”
People
Related News
30 October 2024
In the News
Gregory Husisian Discusses Antidumping and Countervailing Duties in Solar
Foley & Lardner LLP partner Gregory Husisian offers insight on antidumping and countervailing duties (AD/CVD) in the solar industry in the Solar Power World article, "Unique AD/CVD case brings imported solar racking into spotlight."
30 October 2024
In the News
Donald Schroeder on Massachusetts Gig Driver Ballot Initiative – 'This is just the first round'
Foley & Lardner LLP partner Donald Schroeder commented in the Law360 article, "Mass. Initiative Could Set Up Novel Gig Driver Union Scheme," offering perspective on a ballot initiative in Massachusetts that would extend a form of union rights to ride-hailing drivers.
25 October 2024
In the News
Charles Curley and Joshua Ehrenfeld Featured for Arrival to Foley
Foley & Lardner LLP partners Charles Curley and Joshua Ehrenfeld are highlighted across legal press for their recent arrival to the firm.